Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
EpiAxis Therapeutics Enters Strategic Partnership on Prostate Cancer with Canada's University Health Newtork (UHN)
Read more
Report
Epiaxis Therapeutics Announces Positive Clinical Trial Data For Its New Drug Program To Inhibit Metastatic Breast Cancer
Epiaxis Therapeutics Announces Positive Clinical Trial Data For Its New Drug Program To Inhibit Metastatic Breast Cancer. EpiAxis Therapeutics is based in Sydney, Australia.EpiAxis Therapeutics has announced a pioneering clinical study, showing that an ep
Read more
Report
